Blood News and Research

RSS

Preconception weight loss may not increase obese woman's chances of delivering a healthy baby

Health care professionals often encourage women with obesity to lose weight prior to trying to conceive or start infertility treatments.

18 Jan 2022

Study provides insights into how SARS-CoV-2 impacts the brain

Some patients who develop new cognitive symptoms after a mild bout of COVID have abnormalities in their cerebrospinal fluid similar to those found in people with other infectious diseases.

18 Jan 2022

Social media use linked with worse physical health indicators among college students

Social media use was correlated with worse physical health indicators among college students, according to a new study published in the peer-reviewed journal Cyberpsychology, Behavior, and Social Networking.

18 Jan 2022

Subcutaneous nanotherapy can make immunomodulation more effective in people with type 1 diabetes

Individuals living with type 1 diabetes must carefully follow prescribed insulin regimens every day, receiving injections of the hormone via syringe, insulin pump or some other device. And without viable long-term treatments, this course of treatment is a lifelong sentence.

18 Jan 2022

Risk factors affect cardiovascular disease risk even in patients with no coronary artery calcium

Among patients with no detectable coronary artery calcium, those who smoke, have diabetes or hypertension nonetheless have the highest risk of cardiovascular disease events, according to a study published in the journal Circulation.

18 Jan 2022

COVID-19 during pregnancy may induce fetal immune response even in the absence of placental infection

SARS-CoV-2 infection during pregnancy may cause inflammatory immune responses in the fetus, even if the virus does not infect the placenta, according to a small National Institutes of Health study.

18 Jan 2022

New findings support the routine use of remdesivir in hospitalized COVID-19 patients

Remdesivir, an antiviral drug used to treat COVID-19, increased the likelihood of clinical improvement in COVID-19 patients on low-flow oxygen or no oxygen, according to a new study authored by the Johns Hopkins University School of Medicine, the Johns Hopkins Bloomberg School of Public Health, HCA Healthcare, and Genospace.

18 Jan 2022

Study: Nearly 30% of people with blinding retinal disease can safely stop eye injection therapy

In a preliminary study of 106 people with "wet" age-related macular degeneration, Johns Hopkins Medicine researchers report that as many as a third of those with the blinding retinal disease may someday be able to safely stop eye injection therapy without further vision loss.

18 Jan 2022

Study finds COVID booster maintains strong T cell response against Omicron

New study results posted to the medRxiv* preprint server found that COVID vaccine boosters increase immunity by enhancing T cell immune memory. In the face of the severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) Omicron variant, vaccinated people who had received a third booster shot maintained high T cell responses than people with naturally acquired immunity or vaccine-induced immunity from two doses of the SARS‑CoV‑2 vaccine.

18 Jan 2022

Arterial stiffness in adolescence may be a causal risk factor for insulin resistance and dyslipidemia

Arterial stiffness may be a novel risk factor to be targeted in the prevention and treatment of insulin resistance and dyslipidemia from a young age, a new study published in Hypertension today suggests.

18 Jan 2022

New blood test for glioblastoma diagnosis may soon be a reality

Researchers at the University of Sussex are one step further to developing a blood test capable of diagnosing the most aggressive form of brain tumor.

18 Jan 2022

Comparison of antibody responses and vaccine effectiveness in healthcare workers post-primary COVID-19 vaccination

The authors highlight that they have shown that boosted individuals are significantly more protected against SARS-CoV-2 infection than any other group

18 Jan 2022

Can meal times affect your risk of glucose intolerance?

In this interview, we speak to Dr. Frank Scheer and Dr. Sarah Chellappa about their latest research that investigated the effect meal times has on glucose intolerance.

18 Jan 2022

DPP4 protein: The connection between severe COVID-19 and diabetes

Researchers explore the relationship between DPP4 and diabetes targets in the management of COVID-19.

17 Jan 2022

SARS-CoV-2 interacts with heparan sulfate to activate the alternative pathway

A new study discusses the activation of the complement system to determine its role in COVID-19-related deaths.

17 Jan 2022

Effects of post-acute COVID-19 on physical and mental health in women

The current study attempts to measure the difference in mood, functional status, and leisure-time physical activity in women with a history of COVID-19.

17 Jan 2022

Study suggests myeloid cell dysregulation is a driver of COVID-19 severity

Researchers determine the driving factors for disease severity and death due to COVID-19.

17 Jan 2022

Study shows SARS-CoV-2 prompts NLRP3 inflammasome activation through spike-ACE2 receptor interaction

New research assesses the NLR family pyrin domain containing 3 (NLRP3) inflammasome activation in response to SARS-CoV-2 and its spike protein, and the effects of this exposure in the presence of a-synuclein protein aggregate fibrils.

17 Jan 2022

New method may help make immunomodulation more effective in individuals with Type 1 diabetes

Individuals living with Type 1 diabetes must carefully follow prescribed insulin regimens every day, receiving injections of the hormone via syringe, insulin pump or some other device. And without viable long-term treatments, this course of treatment is a lifelong sentence.

17 Jan 2022

Dexamethasone shown to upregulate innate and adaptive immune responses in COVID-19 acute respiratory distress syndrome patients

In a new study, researchers used per protocol bronchoalveolar lavage fluid (BALF) samples after intubation to evaluate the transcriptomic profiles of the local pulmonary host responses during early-stage severe coronavirus disease 2019 (COVID-19) acute respiratory distress syndrome (CARDS), non-COVID-19 ARDS, and sepsis.

17 Jan 2022

Blood News and Research

Preconception weight loss may not increase obese woman's chances of delivering a healthy baby

Study provides insights into how SARS-CoV-2 impacts the brain

Social media use linked with worse physical health indicators among college students

Subcutaneous nanotherapy can make immunomodulation more effective in people with type 1 diabetes

Risk factors affect cardiovascular disease risk even in patients with no coronary artery calcium

COVID-19 during pregnancy may induce fetal immune response even in the absence of placental infection

New findings support the routine use of remdesivir in hospitalized COVID-19 patients

Study: Nearly 30% of people with blinding retinal disease can safely stop eye injection therapy

Study finds COVID booster maintains strong T cell response against Omicron

Arterial stiffness in adolescence may be a causal risk factor for insulin resistance and dyslipidemia

New blood test for glioblastoma diagnosis may soon be a reality

Comparison of antibody responses and vaccine effectiveness in healthcare workers post-primary COVID-19 vaccination

Can meal times affect your risk of glucose intolerance?

DPP4 protein: The connection between severe COVID-19 and diabetes

SARS-CoV-2 interacts with heparan sulfate to activate the alternative pathway

Effects of post-acute COVID-19 on physical and mental health in women

Study suggests myeloid cell dysregulation is a driver of COVID-19 severity

Study shows SARS-CoV-2 prompts NLRP3 inflammasome activation through spike-ACE2 receptor interaction

New method may help make immunomodulation more effective in individuals with Type 1 diabetes

Dexamethasone shown to upregulate innate and adaptive immune responses in COVID-19 acute respiratory distress syndrome patients

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News